Advertisement

Topics

Global Lung Cancer Liquid Biopsy Market 20172021 [Report Updated: 24112017] Prices from USD $3500

11:22 EST 6 Dec 2017 | BioPortfolio Report Blog

About Lung Cancer Liquid Biopsy


A liquid biopsy helps to identify freefloating tumor DNA also known as circulating DNA within the blood sample of a patient. Lung cancer liquid biopsy helps to detect the epidermal growth factor receptor EGFR mutation and other identified mutations, which are responsible for lung cancer. It is observed that the use of a liquid biopsy to identify carcinogenic cells of lungs will help in the early diagnosis of lung cancer.


Technavio's analysts forecast the global lung cancer liquid biopsy market to grow at a CAGR of 17.15% during the period 20172021.


Covered in this report

The report covers the present scenario and the growth prospects of the global lung cancer liquid biopsy market for 20172021. To calculate the market size, the report considers the sales and values of lung cancer liquid biopsy assays.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA


Technavio's report, Global Lung Cancer Liquid Biopsy Market 20172021, has been prepared based on an indepth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.


Key vendors

Biocept

Exosome Diagnostics

F. HoffmannLa Roche

QIAGEN

Other prominent vendors

AccuraGen

Agena Bioscience

BARD1

BGI

Biodesix

BioRad Laboratories

Cancer Genetics

CellMax Life

Circulogene

CLEARBRIDGE BIOMEDICS

Cynvenio Biosystems

EntroGen

Epic Sciences

Epigenomics

Fluxion Biosciences

Freenome

Gencurix

Genetracer Biotech

Genomic Health

Grail

Guardant Health

HeliTec

Inivata

Lonza

MedGenome

Nanoview Diagnostics

Natera

Novogene

OncoCyte

OncoDNA

Pathway Genomics

Personal Genome Diagnostics

Predicine

Shuwen Biotech

Sysmex

Thermo Fisher Scientific

Transgenomic

Trovagene

Market driver

Rising incidence of lung cancer

For a full, detailed list, view our report


Market challenge

High cost of lab testing procedure

For a full, detailed list, view our report


Market trend

Vendors' focus on clinical trials

For a full, detailed list, view our report


Key questions answered in this report

What will the market size be in 2021 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?


You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Original Article: Global Lung Cancer Liquid Biopsy Market 20172021 [Report Updated: 24112017] Prices from USD $3500

NEXT ARTICLE

More From BioPortfolio on "Global Lung Cancer Liquid Biopsy Market 20172021 [Report Updated: 24112017] Prices from USD $3500"

Quick Search
Advertisement
 

Relevant Topics

Lung Cancer
Lung cancer is the uncontrolled cell growth in tissues of the lung. Originating in the lungs, this growth may invade adjacent tissues and infiltrate beyond the lungs. Lung cancer, the most common cause of cancer-related death in men and women, is respons...

Bioinformatics
Bioinformatics is the application of computer software and hardware to the management of biological data to create useful information. Computers are used to gather, store, analyze and integrate biological and genetic information which can then be applied...